Gene · 7832
Papers2,269
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,269
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Micro RNAs as a Diagnostic Marker between Glioma and Primary CNS Lymphoma: A Systematic Review. | Cancers (Basel) | 2023 | 37509289 | PubTator, text mining | PubMed |
| Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. | J Exp Clin Cancer Res | 2023 | 37507802 | PubTator, text mining | PubMed |
| Linoleic acid derivatives target miR-361-3p/BTG2 to confer anticancer effects in acute myeloid leukemia. | J Biochem Mol Toxicol | 2023 | 37497988 | PubTator, text mining | PubMed |
| Effects of DNA, RNA, and Protein Methylation on the Regulation of Ferroptosis. | Int J Biol Sci | 2023 | 37497000 | PubTator, text mining | PubMed |
| Introduction of Asymmetry in the Fused 4-Oxalocrotonate Tautomerases. | Biochemistry | 2023 | 37490761 | PubTator, text mining | PubMed |
| Integrative Analysis of Inflammatory Response-Related Gene for Predicting Prognosis and Immunotherapy in Glioma. | J Mol Neurosci | 2023 | 37488455 | PubTator, text mining | PubMed |
| Enhancement of the SESN2-SHP cascade by melatonin ameliorates hepatic gluconeogenesis by inhibiting the CRBN-BTG2-CREBH signaling pathway. | Exp Mol Med | 2023 | 37488285 | PubTator, text mining | PubMed |
| Extracellular vesicles in renal cell carcinoma: challenges and opportunities coexist. | Front Immunol | 2023 | 37469514 | PubTator, text mining | PubMed |
| Identification of Novel Diagnostic Biomarkers and Classification Patterns for Osteoarthritis by Analyzing a Specific Set of Genes Related to Inflammation. | Inflammation | 2023 | 37462886 | PubTator, text mining | PubMed |
| Replication Protein A1 is essential for DNA damage repair during mammalian oogenesis. | bioRxiv | 2023 | 37461444 | PubTator, text mining | PubMed |
| Transcriptomic analysis of spinal cord regeneration after injury in Cynops orientalis. | Neural Regen Res | 2023 | 37449639 | PubTator, text mining | PubMed |
| GSK-3 Inhibitor Elraglusib Enhances Tumor-Infiltrating Immune Cell Activation in Tumor Biopsies and Synergizes with Anti-PD-L1 in a Murine Model of Colorectal Cancer. | Int J Mol Sci | 2023 | 37446056 | PubTator, text mining | PubMed |
| WDR82-Mediated H3K4me3 Is Associated with Tumor Proliferation and Therapeutic Efficacy in Pediatric High-Grade Gliomas. | Cancers (Basel) | 2023 | 37444539 | PubTator, text mining | PubMed |
| Hybrid neural network approaches to predict drug-target binding affinity for drug repurposing: screening for potential leads for Alzheimer's disease. | Front Mol Biosci | 2023 | 37441162 | PubTator, text mining | PubMed |
| Pathology and new insights in central nervous system lymphomas. | Curr Opin Oncol | 2023 | 37439536 | PubTator, text mining | PubMed |
| Models of KPTN-related disorder implicate mTOR signalling in cognitive and overgrowth phenotypes. | Brain | 2023 | 37437211 | PubTator, text mining | PubMed |
| Rebalancing liver-infiltrating CCR3+ and CD206+ monocytes improves diet-induced NAFLD. | Cell Rep | 2023 | 37421620 | PubTator, text mining | PubMed |
| Betulinic acid-mediating miRNA-365 inhibited the progression of pancreatic cancer. | Oncol Res | 2023 | 37415745 | PubTator, text mining | PubMed |
| Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial. | Cancer Commun (Lond) | 2023 | 37403255 | PubTator, text mining | PubMed |
| Genotoxicity assessment: opportunities, challenges and perspectives for quantitative evaluations of dose-response data. | Arch Toxicol | 2023 | 37402810 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7832/papers?page=13